M&A Transactional Due Diligence
Major or complex financial transactions require specialized due diligence to reveal serious issues which can impact the deal outcome. Most due diligence occurs before, during or after Mergers and Acquisitions (M&A) deals. This may include looking at deal size, successor liability issues, and whether the deal may even be financially feasible.
Alternatively, more information about a deal may allow for improved opportunities and can afford your team options to secure a competitive advantage.
What information do we look at?
Infortal investigates multiple areas of deal vulnerability, business and executive team reputation, previous affiliations. We assess potential risk exposures in M&A deals to gain a clear understanding of the beneficial ownership and relationship between executive teams and, in some cases, other business entities.
Examples of information that we investigate:
M&A due diligence typically includes extensive legal and financial due diligence, but often business buyers believe they only need to conduct a routine background check to complete their due diligence process. This creates only a very basic view of an executive’s or company’s history. Fewer than 1% of business risks can be identified with employment-style background checks. Yet people often represent the greatest risks in business.
To learn more please download the guide for investors to identify M&A risks.
M&A Due Diligence services help investors and buyers to avoid problems pre and post acquisition. Executives are considered to represent as much as 30% of the value of a business, however, if the buyer or investor knows only the most basic information about the key executives, then they may take on risks that could jeopardize the financial stability, performance and long-term viability of the business or the acquisition itself. If the executives are corrupt or hiding critical information about the company, its revenues, profitability or clients then the deal may fail or worse incur sanctions, fines or penalties by regulatory agencies and these in turn could lead to law suits by stakeholders for non-disclosure of critical data.